INTERNATIONAL PATENT: KIRA PHARMACEUTICALS (US) LLC FILES APPLICATION FOR "ANTI-C5 ANTIBODY FUSED TO FACTOR H FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES"

GENEVA, Nov. 12 -- KIRA PHARMACEUTICALS (US) LLC (245 Main Street, 12th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/027641) for "ANTI-C5 ANTIBODY FUSED TO FACTOR H FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES" on May 02, 2025. With publication no. WO/2025/231454, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SONG, Wenru (c/o Kira Pharmaceuticals (US) LLC245 Main Street, 12th FloorCambridge, Massachusetts 02142), MA, Jay (c/o Kira Pharmaceuticals (US) LLC245 Main Street, 12th F...